US equities
|
MU
$1,075.31
▲+0.96%
NVDA
$231.02
▲+1.16%
SNDK
$1,774.54
▲+1.99%
INTC
$120.86
▲+0.52%
TSLA
$357.30
▲+0.70%
GOOGL
$338.59
▼-1.60%
SPCX
$149.85
▼-0.67%
AMD
$615.24
▲+0.57%
MU
$1,075.31
▲+0.96%
NVDA
$231.02
▲+1.16%
SNDK
$1,774.54
▲+1.99%
INTC
$120.86
▲+0.52%
TSLA
$357.30
▲+0.70%
GOOGL
$338.59
▼-1.60%
SPCX
$149.85
▼-0.67%
AMD
$615.24
▲+0.57%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Integrated Biopharma Inc
(OP:
INBP
)
0.1820
+0.0219 (+13.68%)
Delayed Quote
Updated: 12:03 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Integrated Biopharma Inc
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
September 25, 2026
From
Integrated BioPharma, Inc.
Via
ACCESS Newswire
Integrated Biopharma's Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of Operations
August 20, 2026
From
Integrated BioPharma, Inc.
Via
ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
May 08, 2026
Via
ACCESS Newswire
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
February 11, 2026
Via
ACCESS Newswire
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
November 10, 2025
Via
ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024
February 13, 2025
Via
ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
November 13, 2024
Via
ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
September 20, 2024
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
September 23, 2025
Via
ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
May 14, 2025
Via
ACCESS Newswire
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
May 10, 2024
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
February 12, 2024
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
November 09, 2023
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
September 15, 2023
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
May 11, 2023
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
February 10, 2023
Via
ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022
November 10, 2022
Via
ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022
September 13, 2022
Via
ACCESSWIRE
Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
March 21, 2023
Via
ACCESSWIRE
Integrated BioPharma Announces Change in Directors
June 21, 2022
HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's...
From
Integrated BioPharma, Inc.
Via
AccessWire
Topics
Cannabis
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
May 12, 2022
HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the...
From
Integrated BioPharma, Inc.
Via
AccessWire
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
February 10, 2022
HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the...
From
Integrated BioPharma, Inc.
Via
AccessWire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
November 10, 2021
HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the...
From
Integrated BioPharma, Inc.
Via
AccessWire
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
September 02, 2021
HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021....
From
Integrated BioPharma, Inc.
Via
AccessWire
Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing
↗
May 28, 2021
The indices that track trading on OTC Markets saw several changes occur in Q1. Here is a deeper look at the companies that were added and removed in each of the market’s...
Via
Benzinga
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
May 13, 2021
HILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2021. Revenue for the...
From
Integrated BioPharma, Inc.
Via
AccessWire
Integrated BioPharma Announces Launch of Investors Website
April 08, 2021
Integrated BioPharma Announces Launch of Investors Website HILLSIDE, NJ / ACCESSWIRE / April 8, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announces the launch of an...
From
Integrated BioPharma, Inc.
Via
AccessWire
